临床医药文献电子杂志
臨床醫藥文獻電子雜誌
림상의약문헌전자잡지
Journal of Clinical Medical Literature (ElectronicEdition)
2014年
13期
2446-2446,2448
,共2页
肝动脉化疗栓塞%原发性肝癌%生存时间%复发率
肝動脈化療栓塞%原髮性肝癌%生存時間%複髮率
간동맥화료전새%원발성간암%생존시간%복발솔
The hepatic artery embolism chemotherapy%Primary liver cancer%The survival time%The recurrence rate
目的:分析和研究肝动脉化疗栓塞治疗原发性肝癌临床疗效。方法选取我院2012年3月~2014年1月原发性肝癌患者38例,按治疗方法不同将其分为观察组21例与对照组17例。对照组患者仅给予手术治疗;观察组患者在术后加用肝动脉化疗栓塞治疗,将两组患者生存率与复发率进行对比。结果两组患者2年内生存率相比较:观察组高于对照组对比差异具有统计学意义(P<0.05);两组患者2年内复发率相比较:观察组低于对照组对比差异具有统计学意义(P<0.05)。结论将肝动脉化疗栓塞方法应用于原发性肝癌患者治疗中,能够有效提高患者生存时间,对延缓病情发展及提高患者生存质量均有重要意义。
目的:分析和研究肝動脈化療栓塞治療原髮性肝癌臨床療效。方法選取我院2012年3月~2014年1月原髮性肝癌患者38例,按治療方法不同將其分為觀察組21例與對照組17例。對照組患者僅給予手術治療;觀察組患者在術後加用肝動脈化療栓塞治療,將兩組患者生存率與複髮率進行對比。結果兩組患者2年內生存率相比較:觀察組高于對照組對比差異具有統計學意義(P<0.05);兩組患者2年內複髮率相比較:觀察組低于對照組對比差異具有統計學意義(P<0.05)。結論將肝動脈化療栓塞方法應用于原髮性肝癌患者治療中,能夠有效提高患者生存時間,對延緩病情髮展及提高患者生存質量均有重要意義。
목적:분석화연구간동맥화료전새치료원발성간암림상료효。방법선취아원2012년3월~2014년1월원발성간암환자38례,안치료방법불동장기분위관찰조21례여대조조17례。대조조환자부급여수술치료;관찰조환자재술후가용간동맥화료전새치료,장량조환자생존솔여복발솔진행대비。결과량조환자2년내생존솔상비교:관찰조고우대조조대비차이구유통계학의의(P<0.05);량조환자2년내복발솔상비교:관찰조저우대조조대비차이구유통계학의의(P<0.05)。결론장간동맥화료전새방법응용우원발성간암환자치료중,능구유효제고환자생존시간,대연완병정발전급제고환자생존질량균유중요의의。
Objective To analyze and research the clinical curative effect of hepatic arterial chemo embolization of primary liver cancer.Selection Methods Our hospital in March 2012 - January 2014,38 patients with primary liver cancer,according to the different treatments will be divided into the observation group of 21 cases of 17 cases with control group.Control group patients give only surgery; Observation group of patients with hepatic artery embolism chemotherapy after surgery treatment,two groups of patients survival rate and recurrence rate were compared. Results Two groups of patients compared 2 years survival rate: observation group is higher than the control group (P<0.05); Compared two groups of patients with recurrence 2 years: observation group is lower than the control group (P<0.05). Conclusion The method of hepatic artery embolism chemotherapy is used in the treatment of patients with primary liver cancer,can effectively improve the patients survival time,to slow disease progression and improve quality of life of patients.